(Q26751386)

English

Precision medicine in patients with allergic diseases: Airway diseases and atopic dermatitis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology

scientific article

In more languages

Statements

scholarly article

0 references

Precision medicine in patients with allergic diseases: Airway diseases and atopic dermatitis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology (English)

0 references

0 references

1 reference

based on heuristic

inferred from title

Peter Schmid-Grendelmeier

10

object named as

Peter Schmid-Grendelmeier

0 references

Peter W Hellings

object named as

Peter W Hellings

3

0 references

object named as

Hans-Uwe Simon

11

0 references

7

object named as

Marek Jutel

0 references

Robert F Lemanske

2

object named as

Robert F Lemanske

0 references

4

object named as

Cezmi A Akdis

0 references

13

object named as

Ioana Agache

0 references

8

object named as

Peck Y Ong

0 references

Antonella Muraro

1

object named as

Antonella Muraro

0 references

5

object named as

Thomas Bieber

0 references

6

object named as

Thomas B Casale

0 references

12

object named as

Sven F Seys

0 references

author name string

Lars K Poulsen

9

0 references

language of work or name

0 references

publication date

May 2016

0 references

The Journal of Allergy and Clinical Immunology

0 references

137

0 references

5

0 references

1347-58

0 references

The Complex Type 2 Endotype in Allergy and Asthma: From Laboratory to Bedside

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunohistology of the nasal mucosa in seasonal allergic rhinitis: increases in activated eosinophils and epithelial mast cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Barrier Epithelial Cells and the Control of Type 2 Immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Leptin is an eosinophil survival factor.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Epithelium dysfunction in asthma

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased sputum and bronchial biopsy IL-13 expression in severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Accumulation of intraepithelial mast cells with a unique protease phenotype in T(H)2-high asthma

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Defective epithelial barrier function in asthma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulator of G protein signaling 2 is a key modulator of airway hyperresponsiveness.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Defective epithelial barrier in chronic rhinosinusitis: the regulation of tight junctions by IFN-γ and IL-4.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

High eosinophil count: a potential biomarker for assessing successful omalizumab treatment effects.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Prominent role of IFN-γ in patients with aspirin-exacerbated respiratory disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Measures of gene expression in sputum cells can identify TH2-high and TH2-low subtypes of asthma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Capsaicin treatment reduces nasal hyperreactivity and transient receptor potential cation channel subfamily V, receptor 1 (TRPV1) overexpression in patients with idiopathic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: a 12-month follow-up analysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Sputum gene expression signature of 6 biomarkers discriminates asthma inflammatory phenotypes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased frequency of dual-positive TH2/TH17 cells in bronchoalveolar lavage fluid characterizes a population of patients with severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of novel immune phenotypes for allergic and nonallergic childhood asthma

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Application of moisturizer to neonates prevents development of atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: A meta-analysis of the literature

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Biomarker-based asthma phenotypes of corticosteroid response

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Asthma phenotypes and the use of biologic medications in asthma and allergic disease: the next steps toward personalized care

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Severe atopic dermatitis is characterized by selective expansion of circulating TH2/TC2 and TH22/TC22, but not TH17/TC17, cells within the skin-homing T-cell population

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Distinct endotypes of steroid-resistant asthma characterized by IL-17A(high) and IFN-γ(high) immunophenotypes: Potential benefits of calcitriol

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Vanin-1 expression and methylation discriminate pediatric asthma corticosteroid treatment response

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Measuring the corticosteroid responsiveness endophenotype in asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Biomarkers to predict inhaled corticosteroid response.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

International consensus on allergy immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Early pediatric atopic dermatitis shows only a cutaneous lymphocyte antigen (CLA)(+) TH2/TH1 cell imbalance, whereas adults acquire CLA(+) TH22/TC22 cell subsets

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Impaired barrier function in patients with house dust mite-induced allergic rhinitis is accompanied by decreased occludin and zonula occludens-1 expression.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

International Consensus on Allergen Immunotherapy II: Mechanisms, standardization, and pharmacoeconomics

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Proinflammatory mediators in nasal lavage of subjects with occupational rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Strategic paths for biomarker qualification

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomised, double-blind, placebo-controlled, phase 2b trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

TSLP induces mast cell development and aggravates allergic reactions through the activation of MDM2 and STAT6.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

The immunology of asthma

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Asthma phenotypes: the evolution from clinical to molecular approaches

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Type 2 inflammation in asthma--present in most, absent in many

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Biomarkers and surrogate end points for fit-for-purpose development and regulatory evaluation of new drugs

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Mepolizumab for prednisone-dependent asthma with sputum eosinophilia

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Mepolizumab and exacerbations of refractory eosinophilic asthma

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Lebrikizumab treatment in adults with asthma

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Dupilumab treatment in adults with moderate-to-severe atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Mepolizumab treatment in patients with severe eosinophilic asthma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

A new initiative on precision medicine

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

TH2 cytokine expression in bronchoalveolar lavage fluid T lymphocytes and bronchial submucosa is a feature of asthma and eosinophilic bronchitis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

From phenotypes to endotypes to asthma treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Uncontrolled allergic rhinitis and chronic rhinosinusitis: where do we stand today?

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Occupational upper airway disease: how work affects the nose.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Heightened response of eosinophilic asthmatic patients to the CRTH2 antagonist OC000459.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Phenotypes and endotypes of rhinitis and their impact on management: a PRACTALL report

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Exaggerated IDO1 expression and activity in Langerhans cells from patients with atopic dermatitis upon viral stimulation: a potential predictive biomarker for high risk of Eczema herpeticum

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

The first trial of CIM331, a humanized antihuman interleukin-31 receptor A antibody, in healthy volunteers and patients with atopic dermatitis to evaluate safety, tolerability and pharmacokinetics of a single dose in a randomized, double-blind, plac

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunomodulatory effects of IL-23 and IL-17 in a mouse model of allergic rhinitis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Sputum cytokine mapping reveals an 'IL-5, IL-17A, IL-25-high' pattern associated with poorly controlled asthma

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Predicting steroid responsiveness in patients with asthma using exhaled breath profiling.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Impaired macrophage phagocytosis in non-eosinophilic asthma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

World Health Organization; GA(2)LEN; AllerGen. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Untangling asthma phenotypes and endotypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Atopic dermatitis: a candidate for disease-modifying strategy

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of airway inflammation by quantitative Th1/Th2 cytokine mRNA measurement in sputum of asthma patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Novel targeted therapies for eosinophil-associated diseases and allergy

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Overview of biomarkers and surrogate endpoints in drug development

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased interleukin-4, interleukin-5, and interferon-gamma in airway CD4+ and CD8+ T cells in atopic asthma

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

T-helper type 2-driven inflammation defines major subphenotypes of asthma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

An association between L-arginine/asymmetric dimethyl arginine balance, obesity, and the age of asthma onset phenotype

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of airway microbiome on corticosteroid responsiveness in asthma

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Obese individuals with asthma preferentially have a high IL-5/IL-17A/IL-25 sputum inflammatory pattern.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Electronic nose identifies bronchoalveolar lavage fluid eosinophils in asthma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

High IFN-γ and low SLPI mark severe asthma in mice and humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-17 cytokine signalling in patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx?

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Activated p38 MAPK in Peripheral Blood Monocytes of Steroid Resistant Asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACI.2016.03.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.JACI.2016.03.010

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q26751386&oldid=1906407025"